ATE177474T1 - Rekombinanter impfstoff zur geburtenkontrolle - Google Patents

Rekombinanter impfstoff zur geburtenkontrolle

Info

Publication number: ATE177474T1
Authority: AT; Austria
Prior art keywords: birth control; recombinant; recombinant vaccine; vaccine; protein
Prior art date: 1989-09-29

Application number

AT90912568T

Other languages

English (en)

Inventor

Gursaran Prasad Talwar

Jay Srinivasan

Sekhar Chakrabarti

Original Assignee

Nat Inst Immunology

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-09-29

Filing date

1990-08-31

Publication date

1999-03-15

1990-08-31 Application filed by Nat Inst Immunology filed Critical Nat Inst Immunology

1999-03-15 Application granted granted Critical

1999-03-15 Publication of ATE177474T1 publication Critical patent/ATE177474T1/de

Links

108010008038 Synthetic Vaccines Proteins 0.000 title 1
229940124551 recombinant vaccine Drugs 0.000 title 1
229960005486 vaccine Drugs 0.000 abstract 3
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
108090000623 proteins and genes Proteins 0.000 abstract 2
102000004169 proteins and genes Human genes 0.000 abstract 2
102000011022 Chorionic Gonadotropin Human genes 0.000 abstract 1
108010062540 Chorionic Gonadotropin Proteins 0.000 abstract 1
102000009151 Luteinizing Hormone Human genes 0.000 abstract 1
108010073521 Luteinizing Hormone Proteins 0.000 abstract 1
229940015047 chorionic gonadotropin Drugs 0.000 abstract 1
208000002672 hepatitis B Diseases 0.000 abstract 1
229940040129 luteinizing hormone Drugs 0.000 abstract 1
210000004997 mammalian reproductive system Anatomy 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
244000052769 pathogen Species 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/033—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Endocrinology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Reproductive Health (AREA)
Biochemistry (AREA)
Zoology (AREA)
Biophysics (AREA)
Virology (AREA)
Gastroenterology & Hepatology (AREA)
Biotechnology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
Microbiology (AREA)
Toxicology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT90912568T 1989-09-29 1990-08-31 Rekombinanter impfstoff zur geburtenkontrolle ATE177474T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA000614520A CA1340762C (en)	1989-09-29	1989-09-29	Recombinant birth control vaccine

Publications (1)

Publication Number	Publication Date
ATE177474T1 true ATE177474T1 (de)	1999-03-15

Family

ID=4140797

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90912568T ATE177474T1 (de)	1989-09-29	1990-08-31	Rekombinanter impfstoff zur geburtenkontrolle

Country Status (7)

Country	Link
EP (1)	EP0494158B1 (de)
JP (1)	JP3301488B2 (de)
AT (1)	ATE177474T1 (de)
AU (1)	AU647040B2 (de)
CA (1)	CA1340762C (de)
DE (1)	DE69032996D1 (de)
WO (1)	WO1991005049A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5762931A (en) *	1992-12-31	1998-06-09	National Institute Of Immunology	Anti-cancer utility of HCG vaccines
WO1994015633A1 (en) *	1992-12-31	1994-07-21	The International Development Research Centre	ANTI-CANCER UTILITY OF hCG VACCINES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0224574A4 (de) *	1985-06-04	1988-04-26	Biotech Res Partners Ltd	Autoantigene impfstoffe.
CA1239346A (en) *	1985-06-04	1988-07-19	National Institute Of Immunology	Birth control vaccine

1989
- 1989-09-29 CA CA000614520A patent/CA1340762C/en not_active Expired - Fee Related
1990
- 1990-08-31 DE DE69032996T patent/DE69032996D1/de not_active Expired - Lifetime
- 1990-08-31 EP EP90912568A patent/EP0494158B1/de not_active Expired - Lifetime
- 1990-08-31 AT AT90912568T patent/ATE177474T1/de not_active IP Right Cessation
- 1990-08-31 JP JP51169390A patent/JP3301488B2/ja not_active Expired - Fee Related
- 1990-08-31 WO PCT/CA1990/000276 patent/WO1991005049A1/en not_active Ceased
- 1990-08-31 AU AU61788/90A patent/AU647040B2/en not_active Ceased

Also Published As

Publication number	Publication date
CA1340762C (en)	1999-09-21
DE69032996D1 (de)	1999-04-15
AU6178890A (en)	1991-04-28
JPH05502996A (ja)	1993-05-27
WO1991005049A1 (en)	1991-04-18
JP3301488B2 (ja)	2002-07-15
AU647040B2 (en)	1994-03-17
EP0494158A1 (de)	1992-07-15
EP0494158B1 (de)	1999-03-10

Similar Documents

Publication	Publication Date	Title
Low et al.	1982	Chemical characterization of thymosin beta 4.
EP0276166A3 (de)	1989-12-27	Zusammensetzung und Verfahren zur Erzeugen einer Superovulation beim Vieh
ES2009948A6 (es)	1989-10-16	Procedimiento de preparacion de una proteina procedente de una hormona estimulante folicular urinaria, mediante proceso de inmunopurificacion de un concentrado urinario post-menopausico.
ES2054692T3 (es)	1994-08-16	Polipeptidos sinteticos y anticuerpos relacionados con el antigeno difuso temprano del virus de epstein-barr.
DE3786649D1 (de)	1993-08-26	Pferde-gamma-interferon.
NL300044I2 (nl)	2001-12-01	Materiaal en methoden voor de bereiding van een heterodimeer humaan LH met een Met 42 Val55 alfa-subeenheid.
ES2062514T3 (es)	1994-12-16	Sistema de procesamiento de levadura que comprende un aminoacido cargado negativamente adyacente al sitio de procesamiento.
AR013139A1 (es)	2000-12-13	Analogos de hormonas glicoproteicas entrecruzados de disulfuro, uso de dichos analogos para preparar medicamentos, composicion farmaceutica, uso de dicha composicion para preparar medicamentos, y proceso para la preparacion de dichos analogos.
ATE154638T1 (de)	1997-07-15	Mutanten von interleukin-3
DE69615026D1 (de)	2001-10-11	Ein verbessertes peptid, immunogene zusammensetzung und impfstoff oder medizinische präparate, eine methode zur immunisierung von tieren gegen das hormon lhrh und analoge des lhrh-tendem-repeat-peptid und deren verwendung als impfstoff
HU9300192D0 (en)	1993-04-28	Polypeptide compounds promoting growth hormone emission
DE3881023D1 (de)	1993-06-17	Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
DE3751727D1 (de)	1996-04-11	Polypeptide zur verwendung bei der diagnose von mycoplasmainfektionen bei schweinen, sowie rekombinant-dns-verfahren zur herstellung derselben
ATE177474T1 (de)	1999-03-15	Rekombinanter impfstoff zur geburtenkontrolle
ATE65407T1 (de)	1991-08-15	Verfahren zur herbeifuehrung der ovulation.
ES2052762T3 (es)	1994-07-16	Estructuras peptidicas, inmunogenos que las contienen y sus aplicaciones al control de la fertilidad.
ES2102397T3 (es)	1997-08-01	Tratamiento de la enfermedad del ovario policistico.
GR890100541A (el)	1990-10-31	Μεθοδοι για την παραγωγη υπερ-συναγωνιστων γοναδοτροπινης & tsh και οι υπερ-συναγωνιστες που παραγονται με αυτο τον τροπο.
AU5398898A (en)	1998-07-31	Recombinant fusion proteins of the porcine reproductive and respiratory syndrome virus (PRRSV) and its use in diagnosis
GR1000321B (el)	1992-06-25	Ανασυνδυασμενες διαλυτες πρωτεινες για την μεταβολη της ορμονικ σ εκκρισεως.
NO881661D0 (no)	1988-04-15	Humane rhinoviruspeptider.
NO902491D0 (no)	1990-06-05	Proteiner, vaksiner og nukleinsyrer.
McDonough	2003	The second tier of validation—open discussion and sifting through the evidence: commentary
RU96109046A (ru)	1998-08-20	Одноцепочечные формы квартета гликопротеиновых гормонов
Shevchenko et al.	1982	Immunochemical identification and physico-chemical characteristics of specific proteins of seminal plasma

Legal Events

Date	Code	Title	Description
1999-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties